| 词条 | Akorn |
| 释义 |
}}{{Infobox company | name = Akorn Inc. |logo = File:Akorn logo 2019.png | type = Public | location = Forest Lake, Illinois, U.S. | parent = | revenue = {{increase}} $841 million (2017) | traded_as = {{Unbulleted list|{{NASDAQ|AKRX}}|S&P 400 component}} }} Akorn Inc. is an American generic pharmaceuticals manufacturer based in Lake Forest, Illinois. It is a component of the NASDAQ Biotechnology Index. HistoryJohn Kapoor is not the founder but is a major shareholder since the 1990s.[1]Akorn acquired rival Hi-Tech Pharmacal in 2013.[2] In June 2015, it was reported that a hacker was trying to sell an Akorn customer database of more than 50,000 records. Akorn commented that "Although much of the information acquired is publicly available, we are in the process of notifying our valued customers about this incident".[3] In April 2017, Akorn agreed to be acquired by Fresenius for $4.3 billion.[4] These plans were abandoned by Fresenius after Akorn couldn′t meet basic requirements for an acquisition. In October 2018, Akorn received Abbreviated New Drug Application (ANDA) approval from Food and Drug Administration (FDA) for Bimatoprost Ophthalmic Solution, 0.03%.[5] References1. ^{{cite web|title=John Kapoor|url=https://www.forbes.com/profile/john-kapoor/|website=Forbes|accessdate=12 May 2015}} 2. ^{{cite web|url=https://www.reuters.com/article/us-hitechpharmacal-offer-idUSBRE97Q0EL20130827|author=Reuters Editorial|title=Eye drug maker Akorn to buy rival Hi-Tech Pharmacal for $640 million|website=Reuters|accessdate=2 August 2017}} 3. ^{{cite news|title=Akorn Inc. has customer database stolen, records offered to highest bidder|url=http://www.csoonline.com/article/2938032/data-breach/akorn-inc-has-customer-database-stolen-records-offered-to-highest-bidder.html|accessdate=28 June 2015|work=CSO|date=18 June 2015}} 4. ^{{cite web|url=https://www.bloomberg.com/news/articles/2017-04-24/fresenius-agrees-to-buy-akorn-merck-kgaa-biosimilars-business|title=Fresenius Buys Akorn for $4.3 Billion in U.S. Expansion|author=|date=24 April 2017|publisher=|accessdate=23 September 2017|via=www.bloomberg.com}} 5. ^{{Cite news|url=https://www.streetinsider.com/Corporate+News/Akorn+(AKRX)+Receives+ANDA+Approval+from+FDA+for+Bimatoprost+Ophthalmic+Solution,+0.03%25/14690729.html|title=Akorn (AKRX) Receives ANDA Approval from FDA for Bimatoprost Ophthalmic Solution, 0.03%|work=StreetInsider.com|access-date=2018-10-23}} External links
4 : Companies listed on NASDAQ|Biotechnology companies of the United States|Pharmaceutical companies of the United States|Health care companies based in Illinois |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。